Treatment of acute traumatic brain injury with the hormone progesterone provides no significant benefit to patients when compared with placebo, a phase III clinical trial has concluded.
from Today's Healthcare News -- ScienceDaily http://ift.tt/16hcTgu
from Today's Healthcare News -- ScienceDaily http://ift.tt/16hcTgu
No comments:
Post a Comment